Biogen
BIIB
BIIB
994 hedge funds and large institutions have $34.8B invested in Biogen in 2023 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 340 increasing their positions, 362 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 1,026 → 994 (-32)
14% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 101
21% less funds holding in top 10
Funds holding in top 10: 24 → 19 (-5)
Holders
994
Holding in Top 10
19
Calls
$744M
Puts
$674M
Top Buyers
| 1 | +$511M | |
| 2 | +$192M | |
| 3 | +$151M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$111M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$86.2M |
Top Sellers
| 1 | -$198M | |
| 2 | -$193M | |
| 3 | -$148M | |
| 4 |
Two Sigma Advisers
New York
|
-$140M |
| 5 |
D.E. Shaw & Co
New York
|
-$117M |